Gut and Liver
Published by Editorial Office of Gut and Liver
ISSN : 1976-2283 eISSN : 2005-1212
Abbreviation : Gut Liver
Aims & Scope
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology.
Gut and Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology.
The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology.
The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology.
Gut and Liver is jointly owned and operated by 8 affiliated societies in the field of gastroenterology, namely: the Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, the Korean College of Helicobacter and Upper Gastrointestinal Research, the Korean Association for the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, the Korean Pancreatobiliary Association, and the Korean Society of Gastrointestinal Cancer.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3.2 |
2024 | 3.40 |
Journal Rank
Year | Value |
---|---|
2024 | 2915 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 1205 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.344 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 67 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,000.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
Citation: 904
Authors: Laura M., Eldon A.
-
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Citation: 485
Authors: Daniel S., Daejin, David A.
-
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
Citation: 340
Authors: Ran Xu, Wai-Kay, Ching-Lung, Man-Fung
-
NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Citation: 323
Authors: Geoffrey C., Derrick van, Lay, Shivrakumar
-
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
Citation: 280
Authors: Akila De, Stephen R.
-
<i>Clostridium difficile</i>Infection: A Worldwide Disease
Citation: 218
Authors: Kristin E., J. Thomas
-
The Miss Rate for Colorectal Adenoma Determined by Quality-Adjusted, Back-to-Back Colonoscopies
Citation: 193
Authors: Sang Bong, Dong Soo, Joong Ho, Tae Jun, Jong Pyo, Chang Soo